Apheresis Market accounted for over US$ 1.63 billion in 2019. It is anticipated to grow at a CAGR of 8% from 2020 to 2030.
Apheresis refers to the process of collecting specific blood components. These collected blood components, depending on the patient’s condition, are replaced with similar blood components received from donors. It is a technique of separating the cellular and soluble components of blood using a cell separator, either by the centrifuge process or the filtration process. After the separation, the desired components of the blood are removed while the remaining blood components are reinfused back into the patient. The entire procedure is painless and takes typically two hours or slightly longer than blood donation.
Major Key Players of the Apheresis Market are:
TERUMO BCT, INC., Fresenius SE & Co. KGaA, Haemonetics Corporation, Baxter., Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Cerus Corporation., KANEKA CORPORATION, KAWASUMI LABORATORIES. INC., Nikkiso Co., Ltd, and others.
No comments:
Post a Comment